objective To assess the true association between appropriate prescription of antibiotics and prognosis in patients with sepsis, a key issue in health care and quality improvement strategies.
Introduction
Sepsis is a public health problem with great impact on morbidity and mortality [1, 2] . The EPISEPSIS-Colombia study [3] found an accumulated monthly incidence of 3.61 cases/100 admissions and a monthly prevalence of 18.6%, with high frequencies of severe sepsis (51%) and septic shock (11%), as well as a 28th-day mortality ranging from 19% in patients in general wards to 46% in septic shock. A recent US-American study [4] based on clinical data from 409 hospitals found sepsis in 6% of adult hospitalisations, and in contrast to claim-based analyses, neither the incidence of sepsis nor the combined outcome of death or discharge to hospice changed significantly between 2009 and 2014. Moreover, populationlevel epidemiologic data for sepsis are scarce or non-existent for low-and middle-income countries [5] , a thorough and comprehensive systematic review suggested global estimates of 19.4 million sepsis cases, with potentially 5.3 million deaths annually [6] .
Current recommendations suggest that once infection is suspected, wide-spectrum antibiotics should be started as soon as possible, followed by controlling the focus of infection [7] . The choice of antibiotics depends on the probable microorganism as well as the risk factors for bacterial resistance. Ratzinger et al. [8] found, in a subgroup of patients with bacteraemia, an association between mortality and inadequate antibiotic treatment, defined in accordance with the susceptibility of the microbiological isolation. Adequate use of antibiotics should have a positive impact on prognosis. However, there is no conclusive evidence regarding the effect of antibiotic prescription on results of clinical relevance [9, 10] .
The initiation time of the antimicrobial therapy seems an extremely relevant factor. In 2006, Kumar et al. [11] reported a 7.6% rise in mortality for every hour by which the initiation of antibiotics was delayed from the time of septic shock recognition. Studies have shown an association between the delay in administering antibiotics from the moment that the shock is recognised or the triage at emergency rooms (ERs), and a rise in mortality [12] [13] [14] [15] [16] [17] . However, a recent meta-analysis suggests that there is no mortality benefit of administering antibiotics within 3 h of ER triage or within 1 h of shock recognition [18] .
Given the small sample size and the retrospective design of most of previous studies, evidence is uncertain and there are aspects regarding antibiotic prescription and its impact on clinical outcomes that must be evaluated in prospective studies. The objective of this research was to determine the association between adequate prescription of antibiotics in patients with severe sepsis or septic shock, treated at the ER of reference hospitals, and the following outcomes: inpatient mortality, length of hospital stay, admission to the ICU, length of ICU stay, need for renal replacement therapy (RRT) or mechanical ventilation.
Materials and methods
A cohort of severe sepsis or septic shock patients at the ER of three university-centres was recruited: Hospital Pablo Tob on Uribe (HPTU), Hospital General de Medellin (HGM) and Cl ınica las Am ericas (CLA) in MedellinColombia. Collection of clinical records started at HPTU in November 2013, and the study was extended to HGM in August 2014 and to CLA in October 2014, reaching the sample size in March 2016. Data were collected from clinical records, and researchers did not participate in medical or nursing care.
Inclusion criteria required an infection in accordance with the clinical or microbiological criteria of the CDC definitions [19] , and at least one organ/system dysfunction, based on the SOFA score ≥2 [20] , produced or related to the infection, and detected within 24 h prior to being admitted to the study. For the HGM and CLA, in addition to the previous criteria, patients were required to have positive blood cultures. This condition was established because of problems in recruiting and the need to improve the efficiency in the analysis by the infectious disease specialists. Patients referred to another hospital within the first 48 h of admission were excluded, as were patients with known infections who needed prolonged treatments (e.g. tuberculosis, nocardiosis, histoplasmosis) and patients with do-not-resuscitate orders or terminal diseases.
Exposure variables
Antibiotics use were assessed independently, based on clinical records in a case-by-case analysis, by two infectious disease specialists and their differences were discussed by consensus. A third specialist, blinded to the previous appreciations and, based only on clinical records, resolved any disagreement. Independent agreement was reached in 25% and consensus in 72% of the cases, with 3% requiring the third evaluator. Adequate prescription was considered in accordance with the presence of microbiological isolation as follows: in case of positive cultures, if there was agreement between the empirical selection of antibiotics, and the in vitro susceptibility of the isolation obtained; in case of negative cultures, if the antibiotic spectrum was evaluated according to the clinical presentation and severity as well as IDSA guidelines to manage infections [21] . Specialists judged as inadequate those prescriptions not classified as adequate according to the spectrum of activity of the antibiotic. Other exposure variables assessed by the three specialists with the same procedure were: time elapsed between patient's admission to the ER and the first administered dose of antibiotics, route of administration, adequate dose of antibiotics and total administration time. Adequate dose of antibiotics was defined according to the daily dose adjusted by renal function; and total administration time was judged as 'excessive' if it was longer than 2 weeks without clinical justification, default if it was <5 days and adequate otherwise.
Outcome variables
• Primary outcomes: inpatient mortality and length of hospital stay.
• Secondary outcomes: ICU admission, length of ICU stay, renal replacement therapy (RRT) and mechanical ventilation.
The information related to the prescription of antibiotics, clinical outcomes and different variables of interest was taken by a trained research assistant from clinical records. The first prescription for each patient was taken into account, since antibiotic management corresponds to the critical reanimation period during the first 6 h of sepsis identification. The severity of the disease was assessed using the APACHE II [22] and the organ dysfunction was measured using the SOFA [20] . Both scores were determined based on the information obtained within the first 24 h. Comorbidity was defined using the Charlson index [23] .
Sample size
According to Quintero et al., [24] the frequency of antibiotic prescription after 3 or more hours surpasses 50%. This suggests that any of the errors such as choosing an inadequate prescription, starting late an antibiotic treatment or using an inappropriate dose may be present in 60% or more of the cases. Consequently, we considered a 60% frequency of inadequate antibiotic prescription and a relative rise in 33% regarding a 20% control inpatient mortality. Accordingly, at least 600 patients were estimated in the cohort for a sample size with a 0.05 alpha error and a 0.8 power.
Statistical analysis
Variables are presented as means and standard deviations (SD) or medians and interquartile ranges (IQR) or proportions. The primary outcomes inpatient mortality and length of stay were compared, in accordance with different definitions of inadequate use of antibiotics, by chisquare or Kruskal-Wallis tests respectively. In addition, two logistic regression models were fitted for estimation of inpatient mortality risk: one with an independent variable of adequate or inadequate use of antibiotics; and the other with time in hours from the moment the patient was admitted to the ER until the first dose of antibiotics. Both models were adjusted for acknowledged prognostic factors in sepsis: age, SOFA score, Charlson comorbidity index, intra-abdominal or other sources of infection and the time elapsed between ER attention and starting of antibiotics (the later only for the first model). Outcomes like required ICU admission, ICU length of stay, required RRT and mechanical ventilation also underwent comparison, using chi-square or Kruskal-Wallis. For all the comparisons, a P value <0.05 was considered significant and the results of the logistic model were presented as OR with 95% confidence interval.
Results
After 822 patients were screened, 705 were included in analysis ( Figure 1 ). The HPTU contributed the majority of the population (n = 561, 80%), and the most common infection was in the urinary tract (n = 204, 29%). The most important comorbidities were kidney disease (n = 140, 20%) and neoplasm (n = 125, 18%). The median Charlson comorbidity index was 1 (IQR = 0-2), APACHE-II = 14 (IQR = 10-18) and SOFA = 4 (IQR = 2-6). Lactate was ordered upon the admission of 83% of the patients (n = 586), the median value was 2 mmol/l (IQR = 1.1-3.3), and hospital mortality was 21% (n = 148; Table 1 ). Seventy-three (10%) patients were in shock since their ER admission and 188 (58%) were admitted to ICU directly from ER. Blood cultures were ordered for most patients at HPTU (n = 537, 96%) and 47% of them were positive (n = 251). Escherichia coli was the most frequent microorganism, independent of the infection site, followed by Klebsiella pneumoniae and Staphylococcus aureus ( Table 2) . Escherichia coli was resistant to ciprofloxacin in 36% (n = 108) and to gentamicin in 18% (n = 56). Klebsiella pneumoniae presented resistance to ampicillin/sulbactam in 24% (n = 17), to ciprofloxacin in 23% (n = 18) and to cefepime in 17% (n = 12). Staphylococcus aureus was resistant to oxacillin (SAMR) in 20% (n = 10; Table 3 ). For positive-culture patients (n = 545, 77%), the antibiotic spectrum was adequate in 75% (n = 408) and inadequate in 25% (n = 137). In negative-culture patients (n = 160, 23%), the spectrum was adequate in 85.6% (n = 137) and inadequate in 14.4% (n = 23). Hospital stay was a median of 11 (IQR = 7-18) and 12 (IQR = 7-21) days in positive-culture patients with an adequate and inadequate spectrum respectively (P = 0.699); and 10 (IQR = 6-18) and 9 (IQR = 4-12) days in negative-culture patients with an adequate and inadequate spectrum respectively (P = 0.041). Mortality rate in positive-culture patients with an adequate spectrum was 20% (n = 81); in patients with an inadequate spectrum it was 18% (n = 25). Negative-culture patient mortality with an adequate spectrum was 20% (n = 28) and 61% in patients with an inadequate spectrum (n = 14; Table 4 ). No differences were found in positive-culture patients regarding mortality risk using inadequate vs. adequate antibiotics (OR = 0.9, 95% CI = 0.55-1.48). After adjustment for prognostic factors, there were no differences in the estimation of mortality risk (OR = 0.73, 95% IC = 0.41-1.28).
A delay in starting antibiotic treatment, per hour, was not associated with the risk of death in positive-culture patients with any of the adequate or inadequate spectrum empirical antibiotics: OR = 1.04 (95% CI = 0.99-1.08) and OR = 0.98 (95% CI = 0.92-1.04) respectively. These results were very similar when the analysis was restricted to patients with positive blood cultures, patients from HPTU, patients with sepsis-3 definition or patients with septic shock according to both the previous and current definition (data not shown). In negative-culture patients with an adequate empiric spectrum of antibiotics (n = 137), no association was found between starting time of antibiotics and mortality (OR = 0.89; 95% CI = 0.77-1.01). ICU admission occurred in 45% (n = 182) and 43% (n = 59) of positive-culture patients with adequate and inadequate empiric antibiotic spectrum respectively; without differences within each group for ICU admission depending on the starting time of antibiotics (OR = 0.97; 95% CI = 0.93-1.01 and OR = 0.94; 95% CI = 0.89-1.00 respectively). Late admissions to ICU, defined as more than 24 h after admission to ER, were 91 (28%), 70 (77%) with adequate prescription and 21 (23%) with inadequate prescription. There were no clinically significant differences in outcomes according to the other characteristics of antibiotics prescription (Tables 5 and  6 ).
Discussion
In this prospective cohort of patients with severe sepsis or septic shock, specifically in those with a positive culture, no differences in prognosis were found between patients who received an adequate prescription of antibiotics and patients who did not. Time elapsed from the ER admission to the starting of antibiotic treatment was Data are presented as medians and interquartile ranges or numbers with percentage. not associated with hospital mortality in any group. Clinically significant differences were neither observed in relation to other characteristics of adequate prescription of antibiotics nor with other outcomes. The issue of appropriate antibiotic use in critically ill patients is very relevant, because the delay in antibiotics for patients with serious bacterial infections can increase mortality risk, but unnecessary exposure to antibiotics is also potentially harmful. Some studies even suggest an association between more aggressive antibiotic regimens and higher mortality rates [25, 26] .Our percentage of patients with inadequate prescription, according to the isolated microorganism, was similar to one previously reported by Capp et al. [27] in a retrospective cohort, where a population of patients with severe sepsis and positive cultures who were admitted to the ICU were evaluated. In the meta-analysis by Marquet et al. [28] , the percentage of adequate prescription varied widely (22%-85.9%) because the definition of this prescription was also variable in the included studies. Only 29.6% included a definition for both, adequate and inadequate prescription; however, most coincided on microbiological susceptibility of isolation as the parameter to score a prescription. Inpatient mortality was significantly lower in patients who received an adequate prescription (RR = 0.67; 95% CI = 0.56-0.80), but with a significant heterogeneity because of the multiple definitions used. The meta-analysis by Paul et al. [9] found a rise in mortality in patients with an inadequate prescription (adjusted OR = 2.05, 95% CI = 1.69-2.49), but again with a significant heterogeneity (I 2 = 79.7%). There was no clarity in more than half of the studies regarding the definitions of the variables and terms of the inclusion criteria. There was also high variability in the monitoring of patients and there was not enough information available to make statistical adjustments. The authors explained that many factors could have influenced the antibiotic prescription. Those patients who were the sickest most likely received wide spectrum antibiotics, reducing the possibility to uncover the germs responsible for their infections. In contrast, patients with a poor life expectancy most likely received a reduced spectrum of antibiotics based on the lack of influence that the antibiotic choice has on the outcome.
In contrast with previous studies, but in concordance with our results, Davies et al., [29] in a prospective cohort with 2855 surgical patients with sepsis and positive cultures, found that an inadequate treatment was not associated with the mortality risk (RR = 1.0, 95% CI = 0.99-1.02). They suggest that patients with inadequate antibiotics were most likely taken to surgery for infection control, whereas the treatment of patients with an adequate spectrum was mainly based on the antimicrobial itself.
The association between delay in the administration of antibiotics, from the moment of shock recognition or the triage in the ER, and mortality is still controversial [11, 17, 18, 30] . The concept of starting an antibiotic treatment early in severe infections has biological plausibility; nevertheless, is not clear which is the appropriate 'window' of time to administer antibiotics to improve survival in this group of patients. In a retrospective cohort study, Kumar et al. [11] reported that the administration of empirical antibiotics within the first hour after recognising a septic shock was associated with a 79.9% hospital survival. Similar findings have been reported by Ferrer et al. [17] . In a recent retrospective analysis of the New York State Department of Health (NYSDOH) database, [30] reported that patients who received antibiotics in hours 3 through 12 had 14% higher odds of in-hospital death than those who received antibiotics within 3 h (odds ratio, 1.14; 95% CI 1.06-1.22). However, the meta-analysis by Sterling et al. [18] suggests that there is no mortality benefit of administering antibiotics within 3 h of the ER triage or within 1 h of shock recognition. Moreover, in a recent editorial, Singer pointed out that the evidence for this 'each hour delay' is based only on retrospective cohorts from secondary data analysis [31] .
To the best of our knowledge, there are no studies evaluating the impact of an adequate prescription of antibiotics on the requirement of ICU. Our results might suggest that patients with an adequate prescription have a lower frequency of ICU admission. However, this relation could be influenced by factors difficult to weigh, such as family or patient wishes to be admitted to the ICU, or the bed availability. Similarly, it is possible that patients with an inadequate prescription have been sicker and going to ICU in a higher proportion. The latter seems more evident in patients with an inadequate prescription and negative culture, who had the highest SOFA values within the entire cohort.
In the group of negative-culture patients, the use of inadequate antibiotic seems to increase mortality. One possibility is that these patients have a higher frequency of infection in places in which culture isolation is unlikely, such as intra-abdominal infections, or that their infections were caused by anaerobic microorganisms, which do not grow in conventional culture media. Since there was no microbiological information to guide antibiotic adjustments, the insufficient empirical antibiotic will be so, until clinical deterioration guided treatment change. However, at this point, any change was most likely inefficient. Nevertheless, we detected negative cultures with inadequate antibiotics in just 23 patients, which represented 3% of the total study population. Consequently, such a minimal sample size precludes any significant inference.
Our study has several strengths. It is a prospective study that identified patients rigorously, based on their clinical histories. Evaluation of antibiotic prescription was done independently by two, and even three infectious disease specialists to reach a final decision by consensus. There were no losses in the follow-up of any of the participants. In addition, the study included severe septic patients with positive and negative cultures favouring the external validity of the results, constituting a good reflection of the common clinical practices in Colombia. The study also has some limitations. The evaluation process for antibiotic prescription had to be different for positive than for negative-culture patients. In positive cultures, the evaluation was based on the resistance profile, while in the negative-culture group, the evaluation was more complex including aspects like medical status, prevalence of antimicrobial resistance in the city, risk factors and the clinical course of patients. In the literature, there is no reference standard to evaluate antibiotic prescriptions. This is evidenced by the heterogeneity of the methods to define an 'adequate prescription' of antibiotics in positive or negative-culture patients in different studies [32] . Once data analysis began, it was noticed that the estimate of the sample size was inadequate because for detecting an absolute difference of 7% in mortality, approximately 1200 patients were required. This apparent lack of power does not seem to be an explanation for the results, considering that mortality in the group of culture positive patients with an inadequate spectrum seems to be even discreetly lower compared to patients with adequate prescription (18% vs. 20%). However, this sample size is too small to make any conclusion about time to antibiotics and outcome. Even if it is true that a shorter time to therapy is associated with better outcome, the effect size is probably small and would only be seen with large number of patients.
Conclusion
The results of this study did not show any association between an adequate prescription of antibiotics and clinical outcomes like mortality, hospital stay and requirement of invasive mechanical ventilation, or RRT in patients with microbiological confirmation of their infection. By ethical constraints, it is impossible to conduct a RCT to determine accurately the impact of this intervention. Nevertheless, in agreement with previously published studies, a successful approach for these patients must consider aspects that goes beyond early selection and administration of antibiotics. 
